Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Adam, Pavlína | Křížková, Soňa | Heger, Zbyněk | Babula, Petr | Pekařík, Vladimír | Vaculovičoá, Markéta | Gomes, Cláudio M. | Kizek, René | Adam, Vojtěch
Article Type: Review Article
Abstract: Prion and other amyloid-forming diseases represent a group of neurodegenerative disorders that affect both animals and humans. The role of metal ions, especially copper and zinc is studied intensively in connection with these diseases. Their involvement in protein misfolding and aggregation and their role in creation of reactive oxygen species have been shown. Recent data also show that metal ions not only bind the proteins with high affinity, but also modify their biochemical properties, making them important players in prion-related diseases. In particular, the level of zinc ions is tightly regulated by several mechanisms, including transporter proteins and the low …molecular mass thiol-rich metallothioneins. From four metallothionein isoforms, metallothionein-3, a unique brain-specific metalloprotein, plays a crucial role only in this regulation. This review critically evaluates the involvement of metallothioneins in prion- and amyloid-related diseases in connection with the relationship between metallothionein isoforms and metal ion regulation of their homeostasis. Show more
Keywords: Alzheimer’s disease, brain, copper, metallothionein, neurodegenerative disorders, prion protein
DOI: 10.3233/JAD-150984
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 637-656, 2016
Authors: Southam, Katherine A. | Vincent, Adele J. | Small, David H.
Article Type: Research Article
Abstract: Although the cause of Alzheimer’s disease (AD) remains unknown, a number of new findings suggest that the immune system may play a critical role in the early stages of the disease. Genome-wide association studies have identified a wide array of risk-associated genes for AD, many of which are associated with abnormal functioning of immune cells. Microglia are the brain’s immune cells. They play an important role in maintaining the brain’s extracellular environment, including clearance of aggregated proteins such as amyloid-β (Aβ). Recent studies suggest that microglia play a more active role in the brain than initially considered. Specifically, microglia provide …trophic support to neurons and also regulate synapses. Microglial regulation of neuronal activity may have important consequences for AD. In this article we review the function of microglia in AD and examine the possible relationship between microglial dysfunction and network abnormalities, which occur very early in disease pathogenesis. Show more
Keywords: Microglia, network abnormalities, neural networks, phagocytosis, synapse pruning
DOI: 10.3233/JAD-151075
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 657-669, 2016
Authors: Lyoo, Chul Hyoung | Cho, Hanna | Choi, Jae Yong | Hwang, Mi Song | Hong, Sang Kyoon | Kim, Yun Joong | Ryu, Young Hoon | Lee, Myung Sik
Article Type: Short Communication
Abstract: We studied topographic distribution of tau and amyloid-β in a patient with variant Alzheimer’s disease with spastic paraparesis (VarAD) by comparing AD patients. The proband developed progressive memory impairment, dysarthria, and spastic paraparesis at age 23. Heterozygous missense mutation (L166P) was found in exon 6 of presenilin-1 gene. The proband showed prominently increased amyloid binding in striatum and cerebellum and asymmetrical tau binding in the primary sensorimotor cortex contralateral to the side more affected by spasticity. We suspect that upper motor neuron dysfunctions may be attributed to excessive abnormal tau accumulation rather than amyloid-β in the primary motor cortex.
Keywords: Alzheimer’s disease, amyloid, PET, spastic paraplegia, tau protein
DOI: 10.3233/JAD-151052
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 671-675, 2016
Authors: Sierksma, Annerieke S.R. | de Nijs, Laurence | Hoogland, Govert | Vanmierlo, Tim | van Leeuwen, Fred W. | Rutten, Bart P.F. | Steinbusch, Harry W.M. | Prickaerts, Jos | van den Hove, Daniel L.A.
Article Type: Short Communication
Abstract: Treatment of Alzheimer’s disease (AD) patients with the antidepressant fluoxetine is known to improve memory and cognitive function. However, the mechanisms underlying these effects are largely unknown. To unravel these mechanisms, we aimed to treat APPswe/PS1dE9 mice with fluoxetine. Unexpectedly, with time, an increased number of animals displayed seizure behavior and died. Although spontaneous behavioral seizures have been reported previously in this mouse model, the observation of seizures and death consequential to fluoxetine treatment is new. Our results warrant further research on the underlying mechanisms as this may refine the treatment of AD patients.
Keywords: Alzheimer’s disease, APPswe/PS1dE9, epilepsy, fluoxetine, premature death, seizure
DOI: 10.3233/JAD-151066
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 677-682, 2016
Authors: Stoeck, Katharina | Psychogios, Marios Nikos | Ohlenbusch, Andreas | Steinfeld, Robert | Schmidt, Jens
Article Type: Research Article
Abstract: A 48-year-old male patient presented with personality changes and progressive memory loss over 2 years with initially suspected Hashimoto’s encephalopathy. Strategy of diagnostic workup of early onset dementia included dementia from neurodegenerative, neuroinflammatory, metabolic/toxic, and psychiatric origin. The patient’s neurological exam was normal. MRI revealed a leukencephalopathy, predominantly in the frontal periventricular white matter, without notable changes over 2 years. On neurophysiological examination, prolonged central conduction times and a sensorimotor polyneuropathy were noted. Neuropsychological impairment included disorientation in place and a reduced short time memory. Behavioral alterations were predominated by sudden mood changes and disinhibition. Cerebrospinal fluid was normal. Despite …presence of thyroid autoantibodies, glucocorticosteroid treatment did not improve the dementia. A metachromatic leukodystrophy was diagnosed by decreased arylsulfatase-A activity in leucocytes/fibroblasts and identification of a compound heterozygous mutation in the ARSA gene: c.542T>G (exon 3) and the novel mutation c.1013T>C (exon 6). Pathogenic function was suggested by bioinformatic mutation search. In a patient with early onset dementia, strategic diagnostic workup including genetic assessment revealed an adult-onset metachromatic leukodystrophy with a novel mutation in the arylsulfatase A gene. Show more
Keywords: Arylsulfatase A, early onset dementia, genetic testing, late-onset metachromatic leukodystrophy
DOI: 10.3233/JAD-150819
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 683-687, 2016
Authors: Peters, Christian | Bascuñán, Denisse | Opazo, Carlos | Aguayo, Luis G.
Article Type: Research Article
Abstract: A major characteristic of Alzheimer’s disease (AD) is the presence of amyloid-β peptide (Aβ) oligomers and aggregates in the brain. It is known that Aβ oligomers interact with the neuronal membrane and induce perforations that cause an influx of calcium ions and enhance the release of synaptic vesicles leading to a delayed synaptic failure by vesicle depletion. To better understand the mechanism by which Aβ exerts its effect on the plasma membrane, we evaluated three Aβ fragments derived from different regions of Aβ1 - 42 ; Aβ1 - 28 from the N-terminal region, Aβ25 - 35 from the central region, and Aβ17 - 42 from …the C-terminal region. The neuronal activities of these fragments were examined with patch clamp, immunofluorescence, transmission electron microscopy, aggregation assays, calcium imaging, and MTT reduction assays. The present results indicate that the fragment Aβ1 - 28 contributes to aggregation, an increase in intracellular calcium and synaptotoxicity, but is not involved in membrane perforation; Aβ25 - 35 is important for membrane perforation, calcium increase, and synaptotoxicity; and Aβ17 - 42 induced mitochondrial toxicity similar to the full length Aβ1 - 42 , but was unable to induce membrane perforation and calcium increase, supporting the idea that it is less toxic in the non-amyloidogenic pathway. Show more
Keywords: Alzheimer’s disease, amyloid, membranes, peptides, pore
DOI: 10.3233/JAD-150896
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 689-699, 2016
Authors: Bonet-Costa, Vicent | Herranz-Pérez, Vicente | Blanco-Gandía, MariCarmen | Mas-Bargues, Cristina | Inglés, Marta | Garcia-Tarraga, Patricia | Rodriguez-Arias, Marta | Miñarro, Jose | Borras, Consuelo | Garcia-Verdugo, Jose Manuel | Viña, Jose
Article Type: Research Article
Abstract: Amyloid-β (Aβ) clearance from brain, which is decreased in Alzheimer’s disease, is facilitated by apolipoprotein E (ApoE). ApoE is upregulated by activation of the retinoid X receptor moiety of the RXR/PPARγ dimeric receptor. Genistein, a non-toxic, well-tested, and inexpensive drug activates the other moiety of the receptor PPARγ . Treatment of an Alzheimer’s disease mouse model with genistein results in a remarkable and rapid improvement in various parameters of cognition, such as hippocampal learning, recognition memory, implicit memory, and odor discrimination. This is associated with a lowering of Aβ levels in brain, in the number and the area of amyloid …plaques (confirmed in vivo by positron emission tomography) as well as in microglial reactivity. Finally, incubation of primary astrocytes with genistein results in a PPARγ -mediated increased release of ApoE. Our results strongly suggest that controlled clinical trials should be performed to test the effect of genistein as treatment of human Alzheimer’s disease. Show more
Keywords: Aging, biomedical research, neurodegenerative disease, neuroscience, phytoestrogens
DOI: 10.3233/JAD-151020
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 701-711, 2016
Authors: Külzow, Nadine | Witte, A. Veronica | Kerti, Lucia | Grittner, Ulrike | Schuchardt, Jan Philipp | Hahn, Andreas | Flöel, Agnes
Article Type: Research Article
Abstract: As the process of Alzheimer’s disease (AD) begins years before disease onset, searching for prevention strategies is of major medical and economic importance. Nutritional supplementation with long-chain polyunsaturated omega-3 fatty acids (LC-n3-FA) may exert beneficial effects on brain structure and function. However, experimental evidence in older adults without clinical dementia is inconsistent, possibly due to low sensitivity of previously employed test batteries for detecting subtle improvements in cognition in healthy individuals. Here we used LOCATO, recently described as a robust and sensitive tool for assessing object-location memory (OLM) in older adults, to evaluate the impact of LC-n3-FA supplementation on learning …and memory formation. In a double-blind placebo-controlled proof-of-concept study, 44 (20 female) cognitively healthy individuals aged 50–75 years received either LC-n3-FA (2,200 mg/day, n = 22) or placebo (n = 22) for 26 weeks. Before and after intervention, memory performance in the OLM-task (primary) was tested. As secondary outcome parameters, performance in Rey Auditory Verbal Learning Test (AVLT), dietary habits, omega-3-index, and other blood-derived parameters were assessed. Omega-3 index increased significantly in the LC-n3-FA group compared with the placebo group. Moreover, recall of object locations was significantly better after LC-n3-FA supplementation compared with placebo. Performance in the AVLT was not significantly affected by LC-n3-FA. This double-blind placebo-controlled proof-of-concept study provides further experimental evidence that LC-n3-FA exert positive effects on memory functions in healthy older adults. Our findings suggest novel strategies to maintain cognitive functions into old age. Show more
Keywords: Cognitive aging, dietary prevention, docosahexaenoic acid, eicosapentaenoic acid, fish oil
DOI: 10.3233/JAD-150886
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 713-725, 2016
Authors: LoBue, Christian | Denney, David | Hynan, Linda S. | Rossetti, Heidi C. | Lacritz, Laura H. | Hart Jr., John | Womack, Kyle B. | Woon, Fu L. | Cullum, C. Munro
Article Type: Research Article
Abstract: This study examined whether history of traumatic brain injury (TBI) is associated with increased risk and earlier onset of mild cognitive impairment (MCI). Subjects with MCI (n = 3,187) and normal cognition (n = 3,244) were obtained from the National Alzheimer’s Coordinating Center database. TBI was categorized based on lifetime reported TBI with loss of consciousness (LOC) without chronic deficit. Logistic regression was used to examine TBI history as a predictor of MCI, adjusted for demographics, apolipoprotein E-ɛ 4 (ApoE4), a composite vascular risk score, and history of psychiatric factors. ANCOVA was used to examine whether age at MCI diagnosis and estimated …age of onset differed between those with (TBI+) and without (TBI–) a history of TBI. TBI history was a significant predictor (p < 0.01) and associated with increased odds of MCI diagnosis in unadjusted (OR = 1.25; 95% CI = 1.05–1.49) and adjusted models, accounting for age, education, ApoE4, and a composite vascular score (OR = 1.32; 95% CI = 1.10–1.58). This association, however, was largely attenuated (OR = 1.14; 95% CI = 0.94–1.37; p = 0.18) after adjustment for reported history of depression. MCI was diagnosed a mean of 2.3 years earlier (p < 0.001) in the TBI+ group, and although TBI+ subjects had an estimated mean of decline 1.7 years earlier, clinician-estimated age of onset failed to differ (p = 0.13) when gender and psychiatric factors were controlled. This is the first report of a possible role for TBI as a risk factor in MCI, but its association may be related to other factors such as gender and depression and requires further investigation. Show more
Keywords: Age of onset, mild cognitive impairment, risk factors, traumatic brain injury
DOI: 10.3233/JAD-150895
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 727-736, 2016
Authors: Moon, Yeonsil | Han, Seol-Heui | Moon, Won-Jin
Article Type: Research Article
Abstract: Background: Emerging evidence suggests that the excessive accumulation of iron in subcortical and deep gray matter has been related to dementia. However, the presence and pattern of iron accumulation in vascular dementia (VaD) and Alzheimer’s disease (AD) are rarely investigated. Objective: To examine and compare the pattern and presence of brain iron accumulation of VaD and AD using quantitative susceptibility mapping (QSM). Materials and Methods: Twelve patients with VaD, 27 patients with AD, and 18 control subjects were recruited in this institutional review-board approved study. Susceptibility maps were reconstructed from a three-dimensional multiecho spoiled gradient-echo sequence. …Four regions of interest were drawn manually on QSM images, namely the globus pallidus, putamen, caudate nucleus, and pulvinar nucleus of the thalamus. Comparisons of patient demographics, and iron concentrations among the VaD, AD, and control subjects were assessed using analysis of variance and post-hoc analyses. The relationships of age and cognitive state with susceptibility values were assessed using partial correlation analysis. Results: In VaD and AD, overall susceptibility values were higher than those of control subjects. A significant difference in susceptibility values was found in the putamen and caudate nucleus (p < 0.001 and p = 0.002, respectively). However, susceptibility values did not differ between VaD and AD. Age and cognitive deficit severity were not related to susceptibility values in the VaD and AD groups. Conclusion: Increased iron deposition in the putamen and caudate nucleus in VaD and AD patients was not associated with age or the severity of cognitive deficits. Further evaluations are needed to determine the temporal changes in iron load and their diagnostic role in dementia pathology. Show more
Keywords: Cognitive decline, imaging, iron
DOI: 10.3233/JAD-151037
Citation: Journal of Alzheimer's Disease, vol. 51, no. 3, pp. 737-745, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl